½ÃÀ庸°í¼­
»óǰÄÚµå
1378545

¼¼°è ¾ç¸· ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Amniotic Membrane Market, By Product Type (Amniotic Membranes, Amniotic Suspensions) By Application, By End User, and By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾ç¸· ½ÃÀåÀº 2023³â¿¡´Â 36¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í ¿¹Ãø±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 13%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 36¾ï 2,000¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018³â-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 13.00% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 85¾ï 1,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ¾ç¸· ½ÃÀå Á¡À¯À²(%), Á¦Ç° À¯Çüº°(2030³â)
Amniotic Membrane Market-IMG1

½ÃÀå ¿ªÇÐ

¾ç¸· ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ±â¼úÀûÀ¸·Î °í±Þ Á¦Ç° °³¹ß°ú ½ÅÁ¦Ç° °³¹ßÀ» À§ÇÑ M&A¿Í °°Àº ¹«±â Àü·«¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­, ÀÌ·¯ÇÑ ¼±ÁøÀûÀÎ Á¦Ç° ½ÃÀå¿¡ ´ëÇÑ ¼Ò°³´Â ¿¹Ãø ±â°£¿¡ °ÉÃÄ ¼¼°è ¾ç¸· ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î(2030³â) 9¿ù 11ÀÏ, ¾È°ú ½ÃÀå¿ë Á¦Ç°À» °³¹ßÇϰí ÀÖ´Â ¹ÙÀÌ¿ÀÀǾàǰȸ»çÀÎ NovaBay Pharmaceuticals, Inc.¿Í Á¦¾àȸ»çÀÎ BioStem Technologies, Inc.´Â NovaBay Pharmaceuticals, Inc.°¡ BioStem Technologies, Inc. ¾ç¸· Á¶Á÷ ÀÌ½ÄÆíÀ» »ó¿ëÈ­ÇÒ ±Ç¸®°¡ ºÎ¿©µÇ¾ú½À´Ï´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¾ç¸· Á¶Á÷ ÀÌ½ÄÆíÀº ´« Ç¥¸éÀ» ¼ö¸®ÇÒ ¶§ º¸È£ ÄÚÆÃÀ¸·Î »ç¿ëÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­´Â ¼¼°è ¾ç¸· ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¾ç¸· ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®À» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¾ç¸· ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¾ç¸· ½ÃÀåÀ» ºÐ¼®Çϴµ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

  • Á¶»çÀÇ ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Å×½ºÆ® ¹ß»ç
  • ¿ªÇÐ
  • ÇÕº´, Àμö ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°è ¾ç¸· ½ÃÀå : COVID-19 °¨¿°ÀÇ ¿µÇ⠺м®

  • °æÁ¦Àû ¿µÇâ
  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • ¼ö¿ä ¹× °ø±Þ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°è ¾ç¸· ½ÃÀå : Á¦Ç° À¯Çüº°(2018-2030³â)

  • ¼Ò°³
  • ¾ç¸·(µ¿°áº¸Á¸ ¾ç¸·, Å»¼ö ¾ç¸·)
  • ¾ç¸· Çöʾ×

Á¦6Àå ¼¼°è ¾ç¸· ½ÃÀå : ¿ëµµº°(2018-2030³â)

  • ¼Ò°³
  • »óó °ü¸®
  • Á¤Çü¿Ü°ú
  • ¾È°ú
  • ±âŸ

Á¦7Àå ¼¼°è ¾ç¸· ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2018-2030³â)

  • ¼Ò°³
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Àü¹® Ŭ¸®´Ð
  • ¿¬±¸±â°ü ¹× Çмú±â°ü

Á¦8Àå ¼¼°è ¾ç¸· ½ÃÀå : Áö¿ªº°(2018-2030³â)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Smith &Nephew.
    • Applied Biologics
    • Organogenesis Holdings Inc
    • Osiris Therapeutics, Inc
    • Alliqua BioMedical, Inc.
    • Amnio Technology, LLC
    • Next Biosciences
    • Integra LifeSciences
    • MiMedx
    • LifeCell International
    • Human Regenerative Technologies, LLC
    • Amniox Medical, Inc
    • Skye Biologics Inc.
    • Wright Medical
    • TissueTech
    • Katena Products, Inc.
    • NuVision Biotherapies
    • Surgenex
    • Ventris Medical

Á¦10Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
BJH 23.11.23

The global amniotic membrane market is estimated to be valued at US$ 3.62 billion in 2023 and is expected to exhibit a CAGR of 13% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.62 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 13.00% 2030 Value Projection: US$ 8.51 Bn
Figure 1. Global Amniotic Membrane Market Share (%), By Product Type, 2023
Amniotic Membrane Market - IMG1

The amniotic membrane, also known as the amnion, is the innermost layer of the placenta that surrounds the fetus during pregnancy. It is a thin but tough membrane that is made up of three layers: the epithelial layer, the basement membrane, and the stroma.The amniotic membrane has several important functions:

1. It forms a protective barrier around the fetus, providing a safe and sterile environment.

2. It contains amniotic fluid, which allows the fetus to move freely, aids in the development of the musculoskeletal system, and helps to regulate temperature.

3. It acts as a cushion to protect the fetus from any impact to the mother's abdomen.

4. It produces various growth factors and cytokines that aid in fetal development.In addition to its role in pregnancy, the amniotic membrane is also used in medical treatments. It has natural therapeutic properties, including anti-inflammatory, anti-fibrotic, anti-microbial, and wound healing properties. This makes it useful in a variety of medical procedures, including eye surgery, skin wound healing, and the treatment of burns. It is also used in regenerative medicine due to its ability to support the growth of stem cells.

Market Dynamics

The key players in the amniotic membrane market are focusing on the development of technologically advanced products and inorganic strategies such as mergers and acquisitions for the development of novel products. Thus, the introduction of such advanced products in the market is expected to drive growth of the global amniotic membrane market over the forecast period. For instance, on September 11, 2023, NovaBay Pharmaceuticals, Inc., a biopharmaceutical company developing products for the eye care market, and BioStem Technologies, Inc., a pharmaceutical company, announced an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies' Amniotic Tissue Allograft, which is intended for use as a protective covering during the repair of ocular surfaces.

Key features of the study:

  • This report provides an in-depth analysis of the global amniotic membrane market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global amniotic membrane market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global amniotic membrane market

Global Amniotic Membrane Market Detailed Segmentation:

  • By Product Type:
    • Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
    • Amniotic Suspensions
  • By Application:
    • Wound Care
    • Orthopedics
    • Ophthalmology
    • Others
  • By End User:
    • Hospital
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Research and Academic Institutes
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Smith & Nephew.
    • Applied Biologics
    • Organogenesis Holdings Inc.
    • Osiris Therapeutics, Inc.
    • Alliqua BioMedical, Inc.
    • Amnio Technology, LLC
    • Next Biosciences
    • Integra LifeSciences
    • MiMedx
    • LifeCell International
    • Human Regenerative Technologies, LLC
    • Amniox Medical, Inc
    • Skye Biologics Inc.
    • Wright Medical
    • TissueTech
    • Katena Products, Inc.
    • NuVision Biotherapies
    • Surgenex
    • Ventris Medical

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Amniotic Membrane Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Amniotic Membrane Market, By Product Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Amniotic Suspensions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Amniotic Membrane Market, By Application, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Wound Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Orthopedics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Ophthalmology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Amniotic Membrane Market, By End User, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Research and Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Amniotic Membrane Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Smith & Nephew.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Applied Biologics
    • Organogenesis Holdings Inc
    • Osiris Therapeutics, Inc
    • Alliqua BioMedical, Inc.
    • Amnio Technology, LLC
    • Next Biosciences
    • Integra LifeSciences
    • MiMedx
    • LifeCell International
    • Human Regenerative Technologies, LLC
    • Amniox Medical, Inc
    • Skye Biologics Inc.
    • Wright Medical
    • TissueTech
    • Katena Products, Inc.
    • NuVision Biotherapies
    • Surgenex
    • Ventris Medical

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦